Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.

Current drug targets - 1 Apr 2010

Gallo D, Ferlini C, Scambia G

Abstract excerpt

Epithelial ovarian cancer is the leading cause of death for gynecological cancer in most of the Western world; lethality ensues from the occurrence of occult metastasis within the peritoneal cavity, a process requiring the acquisition of capacity for migration and invasiveness by ovarian tumor cells (metastatic phenotype), and characterized by a complex series of interrelated cellular events. Unlike most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to Cell Transdifferentiation
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial Cells

Share to Estrogens

Share to Mesoderm

Share to Ovarian Neoplasms

Share to Snail Family Transcription Factors

Source

Identifiers

PMID: 20015012
DOI: 10.2174/138945010790980385

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.PMID 20015012Read ↗

Epithelial–mesenchymal transition in ovarian cancerSemantic proximity Read ↗

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.Semantic proximity Read ↗

Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic interventionSemantic proximity Read ↗

Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionSemantic proximity Read ↗

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Defining the E-Cadherin Repressor Interactome in Epithelial-Mesenchymal Transition: The PMC42 Model as a Case StudySemantic proximity Read ↗

Similarities in Mechanisms of Ovarian Cancer Metastasis and Brain Glioblastoma Multiforme Invasion Suggest Common Therapeutic TargetsSemantic proximity Read ↗

Silencing of Epidermal Growth Factor-like Domain 8 Promotes Proliferation and Cancer Aggressiveness in Human Ovarian Cancer Cells by Activating ERK/MAPK Signaling CascadesSemantic proximity Read ↗

Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.Semantic proximity Read ↗

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and ChallengesSemantic proximity Read ↗

The influence of menstrual cycle and endometriosis on endometrial expression of epithelial-to-mesenchymal transition (EMT)-related genesSemantic proximity Read ↗

E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressivenessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.